Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey
暂无分享,去创建一个
[1] U. Paasch,et al. Mycology – an update Part 3: Dermatomycoses: topical and systemic therapy , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[2] M. Moga,et al. In vitro susceptibility of dermatophytes isolated from patients with end‐stage renal disease: a case–control study , 2014, Mycoses (Berlin).
[3] V. Fabrizi,et al. Skin and nail mycoses in patients with diabetic foot. , 2013, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.
[4] A. Karaoğlu,et al. Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey. , 2013, Indian journal of dermatology, venereology and leprology.
[5] M. N. Azimah,et al. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia. , 2013, The Southeast Asian journal of tropical medicine and public health.
[6] D. Torgerson,et al. Oral treatments for fungal infections of the skin of the foot. , 2012, The Cochrane database of systematic reviews.
[7] J. Mordes,et al. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. , 2011, The American journal of medicine.
[8] M. Demirbilek,et al. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non‐insulin‐dependent diabetes mellitus: a case‐control study , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[9] B. Elewski,et al. Onychomycosis and diabetes , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[10] R. López-martínez,et al. Onychomycosis Incidence in Type 2 Diabetes Mellitus Patients , 2008, Mycopathologia.
[11] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .
[12] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .
[13] F. Can,et al. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium , 2007, Clinical and experimental dermatology.
[14] J. Szepietowski,et al. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. , 2006, Archives of dermatology.
[15] D. Metin,et al. Onychomycosis in primary school children: association with socioeconomic conditions , 2006, Mycoses.
[16] A. Djeridane,et al. Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria , 2006, Mycoses.
[17] E. Mlinarić-Missoni,et al. Species distribution and frequency of isolation of yeasts and dermatophytes from toe webs of diabetic patients. , 2005, Acta dermatovenerologica Croatica : ADC.
[18] W. Joseph,et al. Common Fungal Infections of the Feet in Patients with Diabetes Mellitus , 2004, Drugs & aging.
[19] S. Dogra,et al. Epidemiology of onychomycosis in patients with diabetes mellitus in India , 2002, International journal of dermatology.
[20] C. Romano,et al. Prevalence of dermatophytic skin and nail infections in diabetic patients , 2001, Mycoses.
[21] A. R. Noriega,et al. Prevalence and Risk Factors of Tinea Unguium and Tinea Pedis in the General Population in Spain , 2000, Journal of Clinical Microbiology.
[22] D. Roseeuw,et al. Achilles foot screening project: preliminary results of patients screened by dermatologists , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.
[23] R. Matucci,et al. Characterization of [3H]substance P binding sites in human skin , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.
[24] R. Summerbell,et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey , 1998, The British journal of dermatology.